Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention
Federal funding for HIV prevention could be slashed, according to The Wall Street Journal.
Gilead Sciences fell 2.52% in premarket trading on the news.
The company makes medication for treating HIV and AIDS. Other biopharma firms also fell.
The move: Gilead Sciences dropped 2.52% in premarket trading, falling to $107.45 per share Wednesday morning. The biopharmaceutical company is up 19.34% for the year.
Why: The stock's decline follows a report from The Wall Street Journal that the US Health and Human Services Department is considering drastic cuts to federal funding for HIV prevention in the US. Gilead makes treatments for adults with HIV.
Sources told the Journal that the funding cutbacks are part of a broader slash that may soon be announced for the Centers for Disease Control and Prevention, with the Trump administration looking to reorganize the agency.
What it means: A reduction to the CDC's HIV budget has implications for drugmakers focused on combating this disease. Aside from Gilead, American depositary shares of GSK fell 2.18% in early trading. The multinational biopharma firm is a majority owner of the HIV-focused company Viiv.
Read the original article on Business Insider
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Opinion - Tariffs are raising health care costs and putting patients at risk
Lately, my bi-weekly calls with my 24-year-old daughter, a medical assistant preparing for med school, are starting to sound more like supply chain audits. She tells me which items are running low at her clinic and how the team is scrambling to provide quality care to patients. Having been raised by a parent who managed global supply chains, she knows these aren't just inventory issues — they are cracks in a fragile health care system now under further strain from President Trump's tariffs and the uncertainty surrounding them. Last year alone, the U.S. imported more than $75 billion in medical devices and supplies. While headlines have focused on potentially higher costs for pharmaceuticals and high-tech medical equipment, the more urgent and often overlooked concern is the availability of basic, everyday lifesaving supplies. Gloves, syringes, sterile water, IV fluids and even diapers may seem mundane, but they are the lifeblood of clinical care. Hospitals spend approximately 25 percent of their budget on these high-volume items. Most of these essentials are imported. For example, two-thirds of non-disposable face masks and 94 percent of plastic gloves used in U.S. health care settings come from China. Already impacted by tariffs implemented last year to counter low-cost imports, these products are now becoming even more expensive. Enteral syringes used to deliver medication or nutrition through feeding tubes are now subject to a staggering 245 percent tariff, according to one group purchasing organization. If trade tensions continue to escalate, we could see a return to pandemic-era supply shortages — or worse. As hospitals prepare for these impacts, it's their patients who will bear the repercussions. The American Hospital Association recently reported that 82 percent of health care leaders expect tariff-related price hikes to increase hospital costs by at least 15 percent within six months. One major health system in Washington projected that tariffs could increase annual costs by $10 to $25 million. With Medicaid reimbursement rates set by the government and private insurance reimbursement rates held in place by contracts, hospitals can't easily pass on these increases. Instead, they absorb the costs and find other cuts, like reducing staffing or delaying upgrades. That could mean longer wait times, postponed procedures and ultimately, worse outcomes for patients. Rural hospitals and community providers already operating on razor-thin margins will feel these burdens most acutely. Close to 200 rural hospitals have closed in the past two decades, and nearly 700, or close to one-third of all additional rural hospitals, are at risk of closing in the near future. When policymakers impose sweeping trade measures without fully considering downstream effects, the entire health care system suffers the consequences. The disruption often costs more than the policy itself, in both dollars and diminished patient care. Health care policy is essential for a productive economy, which is the main goal of the president's tariffs. Medical supplies should be exempted from tariffs. This would help to ensure more consistent pricing and ensure Americans have access to the health care essentials they need. Policymakers can also help bring manufacturing for some of these products back home by investing in more public-private partnerships and supporting infrastructure and workforce development to encourage companies to make these goods in the U.S. Finally, the federal and state governments can reengineer the procurement processes for Medicare and Medicaid, and enact measures to ensure more efficient practices in the private sector to enable competition and fair prices. Pharmacy benefit managers and Group Purchasing Organizations need to work on behalf of the patients, hospitals and clinics to better manage costs, similar to processes in other supply chain systems. Overall, policymakers must understand that while tariffs may shift economic leverage, they also shift risk onto patients. My daughter is learning this lesson on the front lines. She went into medicine to deliver care. Lately, and too often, she's just delivering bad news. Jack Buffington is Supply Chain Management Professor at the University of Denver. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Fast Company
an hour ago
- Fast Company
‘We dissent': NIH scientists sign letter criticizing Trump's cuts in public health research
In his confirmation hearings to lead the National Institutes of Health, Jay Bhattacharya pledged his openness to views that might conflict with his own. 'Dissent,' he said, 'is the very essence of science.' That commitment is being put to the test. On Monday, scores of scientists at the agency sent their Trump-appointed leader a letter titled the Bethesda Declaration, challenging 'policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' It says: 'We dissent.' In a capital where insiders often insist on anonymity to say such things publicly, 92 NIH researchers, program directors, branch chiefs and scientific review officers put their signatures on the letter — and their careers on the line. An additional 250 of their colleagues across the agency endorsed the declaration without using their names. The four-page letter, addressed to Bhattacharya, also was sent to Health Secretary Robert F. Kennedy Jr. and members of Congress who oversee the NIH. White House spokesman Kush Desai defended the administration's approach to federal research and said President Donald Trump is focused on restoring a 'Gold Standard' of science, not 'ideological activism.' Confronting a 'culture of fear' The signers went public in the face of a 'culture of fear and suppression' they say Trump's administration has spread through the federal civil service. 'We are compelled to speak up when our leadership prioritizes political momentum over human safety and faithful stewardship of public resources,' the declaration says. Bhattacharya responded to the declaration by saying it 'has some fundamental misconceptions about the policy directions the NIH has taken in recent months.' 'Nevertheless, respectful dissent in science is productive,' he said in a statement. 'We all want the NIH to succeed.' Named for the agency's headquarters location in Maryland, the Bethesda Declaration details upheaval in the world's premier public health research institution over the course of mere months. It addresses the termination of 2,100 research grants valued at more than $12 billion and some of the human costs that have resulted, such as cutting off medication regimens to participants in clinical trials or leaving them with unmonitored device implants. In one case, an NIH-supported study of multi-drug-resistant tuberculosis in Haiti had to be stopped, ceasing antibiotic treatment mid-course for patients. In a number of cases, trials that were mostly completed were rendered useless without the money to finish and analyze the work, the letter says. 'Ending a $5 million research study when it is 80% complete does not save $1 million,' it says, 'it wastes $4 million.' The mask comes off Jenna Norton, who oversees health disparity research at the agency's National Institute of Diabetes and Digestive and Kidney Diseases, recently appeared at a forum by Sen. Angela Alsobrooks, D-Md., to talk about what's happening at the NIH. At the event, she masked to conceal her identity. Now the mask is off. She was a lead organizer of the declaration. 'I want people to know how bad things are at NIH,' Norton told The Associated Press. The signers said they modeled their indictment after Bhattacharya's Great Barrington Declaration in 2020, when he was a professor at Stanford University Medical School. His declaration drew together likeminded infectious disease epidemiologists and public health scientists who dissented from what they saw as excessive COVID-19 lockdown policies and felt ostracized by the larger public health community that pushed those policies, including the NIH. 'He is proud of his statement, and we are proud of ours,' said Sarah Kobrin, a branch chief at the NIH's National Cancer Institute who signed the Bethesda Declaration. Cancer research is sidelined As chief of the Health Systems and Interventions Research Branch, Kobrin provides scientific oversight of researchers across the country who've been funded by the cancer institute or want to be. Cuts in personnel and money have shifted her work from improving cancer care research to what she sees as minimizing its destruction. 'So much of it is gone — my work,' she said. The 21-year NIH veteran said she signed because she didn't want to be 'a collaborator' in the political manipulation of biomedical science. Ian Morgan, a postdoctoral fellow with the National Institute of General Medical Sciences, also signed the declaration. 'We have a saying in basic science,' he said. 'You go and become a physician if you want to treat thousands of patients. You go and become a researcher if you want to save billions of patients. 'We are doing the research that is going to go and create the cures of the future,' he added. But that won't happen, he said, if Trump's Republican administration prevails with its searing grant cuts. The NIH employees interviewed by the AP emphasized they were speaking for themselves and not for their institutes nor the NIH. Dissenters range across the breadth of NIH Employees from all 27 NIH institutes and centers gave their support to the declaration. Most who signed are intimately involved with evaluating and overseeing extramural research grants. The letter asserts 'NIH trials are being halted without regard to participant safety' and the agency is shirking commitments to trial participants who 'braved personal risk to give the incredible gift of biological samples, understanding that their generosity would fuel scientific discovery and improve health.' The Trump administration has gone at public health research on several fronts, both directly, as part of its broad effort to root out diversity, equity and inclusion values throughout the bureaucracy, and as part of its drive to starve some universities of federal money. At the White House, Desai said Americans 'have lost confidence in our increasingly politicized healthcare and research apparatus that has been obsessed with DEI and COVID, which the majority of Americans moved on from years ago.' A blunt ax swings This has forced 'indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science,' the declaration says. Some NIH employees have previously come forward in televised protests to air grievances, and many walked out of Bhattacharya's town hall with staff. The declaration is the first cohesive effort to register agency-wide dismay with the NIH's direction. The dissenters remind Bhattacharya in their letter of his oft-stated ethic that academic freedom must be a lynchpin in science. With that in place, he said in a statement in April, 'NIH scientists can be certain they are afforded the ability to engage in open, academic discourse as part of their official duties and in their personal capacities without risk of official interference, professional disadvantage or workplace retaliation.' Now it will be seen whether that's enough to protect those NIH employees challenging the Trump administration and him. 'There's a book I read to my kids, and it talks about how you can't be brave if you're not scared,' said Norton, who has three young children. 'I am so scared about doing this, but I am trying to be brave for my kids because it's only going to get harder to speak up.
Yahoo
2 hours ago
- Yahoo
Can I donate blood and how do I do it? Urgent call for donors amid low stocks
The NHS needs 200,000 more regular blood donors to sustain a safe and sufficient supply. Low blood stocks in 2024 prompted an "amber alert', but blood stocks have remained low ever since. NHS Blood and Transplant (NHSBT) is now urging more people to donate to avoid a "red alert", which is a critical situation where public safety is threatened. It described the past year as "challenging" for blood stocks, noting that just under 800,000 people are supporting the entire blood supply in England. The whole process of giving blood takes just one hour. When arriving at a blood donation centre, you are asked to complete a safety check to make sure you can give blood. You will be given 500ml of fluid to drink – drinking this will help the body maintain blood pressure, prevent dizziness and help the body replenish the donated blood. Then, to ensure it is safe to donate blood, medics will confirm your identity and information in your health check. In some cases, a registered nurse will follow up. A drop of blood from your finger is then checked for iron levels. If these levels are too low, the appointment will be rescheduled. Those able to donate will be seated in the waiting area before being called to a donation chair. Here, a cuff will be placed on your arm to maintain a small amount of pressure during the donation before a suitable vein is found and the area is cleaned. Then, a needle will be inserted into your arm to collect your blood into a blood bag, which has your unique donor number on it. A scale weighs the blood and stops when you have donated 470ml - that's just under a pint. The needle is then removed from your arm, and a dressing is applied. The NHS says the process of giving blood should not hurt and should only take about 10 minutes. Although more donors are needed, there are some health, travel and lifestyle reasons that may stop you from donating blood. Donors need to be fit and well, aged between 17 and 65, weigh between 7 stone 12 Ibs (50kg) and 25 stone (158kg) and have suitable veins. However, you can't donate blood if you have cancer, some heart conditions, have tested positive for HIV or are a hepatitis B or C carrier. If you have received blood platelets, plasma or any other blood products after January 1980, or if you have injected non-prescribed drugs including body-building and injectable tanning agents, you also cannot donate. If you've had anal sex with a new partner in the last three months you may have to postpone your donation. If you feel unwell, are pregnant or have had a baby in the last six months, have had a tattoo or piercing, or have recently travelled to certain countries outside the UK, you may also have to wait before you can donate blood. There are thousands of blood donation venues across England, some are permanent and others are pop-ups. Church halls, sports centres, mosques, football stadiums and hotels are all used as pop-up venues. To check where your closest one is, visit the Give Blood website. You will need to book an appointment ahead of your donation which can be done online as soon as you have signed up as a blood donor. There is a 'critical' need for more donors who have the so-called universal blood type, O negative blood, which is needed for treatment in emergencies. The NHS said there is also a need for more Black donors, who are more likely to have specific blood types which can help treat people with sickle cell disease.
